976
HETEROCYCLES, Vol. 77, No. 2, 2009
was 3.5 h. After the work-up and column-chromatography with CHCl3-MeOH (98:2, v/v), 7b (56.6 mg,
98%) was obtained. 7b: mp >300 °C (yellow powder, recrystallized from acetone). IR (KBr): 1630, 1620,
1
1566, 1510, 1487, 1336 cm-1. H-NMR (DMSO-d6) δ: 6.50 (2H, t, J = 2.2 Hz), 7.55 (2H, t, J = 2.2 Hz),
8.14 (1H, dd, J = 8.8, 2.1 Hz), 8.26 (1H, d, J = 2.1 Hz), 8.31 (1H, d, J = 8.8 Hz), 10.06 (1H, s), 13.23 (1H,
br s, disappeared on addition of D2O). MS m/z: 255 (M+). Anal. Calcd for C13H9N3O3·1/4H2O: C, 60.12;
H, 3.49; N, 16.18. Found: C, 60.15; H, 3.63; N, 15.91.
2-(Indol-1-yl)-6-nitroindole-3-carbaldehyde (7c) from 4 — In the general procedure, indole (86.1 mg,
0.74 mmol), NaH (43.0 mg, 1.10 mmol), and 4 (51.6 mg, 0.24 mmol) were used. The reaction time was 2
h. After the work-up and column-chromatography with CHCl3, 7c (68.7 mg, 96%) was obtained. 7c: mp
291-293 °C (yellow powder, recrystallized from EtOAc). IR (KBr): 1630, 1618, 1558, 1508, 1483, 1383,
1327 cm-1. 1H-NMR (DMSO-d6) δ: 6.93 (1H, d, J = 3.4 Hz), 7.28 (1H, t, J = 7.8 Hz), 7.35 (1H, t, J = 7.8
Hz), 7.70 (1H, d, J = 7.8 Hz), 7.76 (1H, d, J = 7.8 Hz), 7.97 (1H, d, J = 3.4 Hz), 8.20 (1H, dd, J = 8.9, 2.5
Hz), 8.35 (1H, d, J = 2.5 Hz), 8.36 (1H, d, J = 8.9 Hz), 9.92 (1H, s), 13.49 (1H, br s, disappeared on
addition of D2O). MS m/z: 305 (M+). Anal. Calcd for C17H11N3O3·1/4H2O: C, 65.91; H, 3.74; N, 13.56.
Found: C, 66.11; H, 3.76; N, 13.29.
2-(Imidazol-1-yl)-6-nitroindole-3-carbaldehyde (7d) from 4 — In the general procedure, imidazole
(53.2 mg, 0.77 mmol), NaH (39.8 mg, 1.00 mmol), and 4 (51.5 mg, 0.23 mmol) were used. The reaction
time was 1.5 h. After the work-up and column-chromatography with CHCl3-MeOH (98:2, v/v), 7d (54.9
mg, 97%) was obtained. 7d: mp 268-272 °C (yellow powder, recrystallized from acetone). IR (KBr):
1660, 1510, 1331 cm-1. 1H-NMR (DMSO-d6) δ: 7.30 (1H, s), 7.94 (1H, s), 8.17 (1H, dd, J = 8.8, 2.2 Hz),
8.34 (1H, d, J = 2.2 Hz), 8.35 (1H, d, J = 8.8 Hz), 8.48 (1H, br s), 9.99 (1H, s). MS m/z: 256 (M+). Anal.
Calcd for C12H8N4O3·1/4H2O: C, 55.28; H, 3.29; N, 21.49. Found: C, 55.53; H, 3.20; N, 21.31.
2-(Benzimidazol-1-yl)-6-nitroindole-3-carbaldehyde (7e) from 4 — In the general procedure,
benzimidazole (86.1 mg, 0.71 mmol), NaH (28.3 mg, 0.71 mmol), and 4 (50.0 mg, 0.23 mmol) were used.
The reaction time was 3.5 h. After the work-up and column-chromatography with EtOAc, 7e (60.4 mg,
87%) was obtained. 7e: mp >300 °C (yellow powder, recrystallized from MeOH). IR (KBr): 1672, 1502,
1338, 1203 cm-1. 1H-NMR (DMSO-d6) δ: 7.41-7.48 (2H, m), 7.75 (1H, dd, J = 7.3, 1.6 Hz), 7.87 (1H, dd,
J = 7.3, 1.6 Hz), 8.21 (1H, dd, J = 8.8, 2.0 Hz), 8.40 (1H, d, J = 8.8 Hz), 8.41 (1H, d, J = 2.0 Hz), 8.87
(1H, s), 9.93 (1H, s), 13.65 (1H, br s, disappeared on addition of D2O). MS m/z: 306 (M+). Anal. Calcd for
C16H10N4O3·1/2H2O: C, 60.95; H, 3.56; N, 17.77. Found: C, 61.02; H, 3.37; N, 17.49.
Nα-Boc-1-(3-formyl-6-nitroindol-2-yl)-L-histidine (8) from 4 — In the general procedure,
Nα-Boc-L-histidine (208.7 mg, 0.82 mmol), NaH (58.0 mg, 1.21 mmol), and 4 (58.0 mg, 0.26 mmol) were
used. The reaction time was 2 h. After the work-up and column-chromatography successively with
CHCl3–MeOH–AcOH (46:10:1, v/v) and CHCl3–MeOH (6:4, v/v), 8 (110.3 mg, 94%) was obtained. 8: